Invesaro

Stocks PHI Financial statements

Financial statements

PLDT Inc. financial statements

Income statement, balance sheet and cash flow statement for the last 10 fiscal years, taken from the XBRL data PLDT Inc. files with the SEC in its annual reports.

In PHP millions, except per-share amounts. Outflows in the cash flow statement are negative.

Income statement

FY2015FY2017FY2017FY2018FY2019FY2019FY2021FY2022FY2023FY2024
Revenue171,103165,262158,933162,914169,187181,004192,186204,362210,953216,833
Cost of revenue17,45318,29313,63314,42713,42912,29512,91714,17215,09214,011
Gross profit153,650146,969145,300148,487155,758168,709179,269190,190195,861202,822
Selling, general and administrative70,28967,19668,99073,91668,23075,25577,68684,47681,87678,308
Operating income31,83524,7039,51113,77339,40136,18240,871-5,06540,69450,487
Interest expense6,2597,3547,3707,0678,55310,08610,40211,75913,75515,500
Interest income7991,0461,4121,9431,7451,210656
Pre-tax income26,63822,07114,56922,81532,33633,02134,15413,50936,43642,693
Income tax4,5631,9091,1033,8429,5508,4417,4782,7749,61210,138
Income from continuing operations26,79711,33526,86532,555
Net income to minority interests101569557265296309250210248
Net income22,06520,00613,37118,91622,52124,28426,36710,48526,61432,307
EBITDA63,35459,15861,42661,01379,05783,66292,94393,56699,135106,475
EPS, basic101.8592.3361.6187.28103.97112.12121.7648.26122.91149.26
EPS, diluted101.8592.3361.6187.28103.97112.12121.7648.26122.91149.26

Balance sheet

FY2015FY2017FY2017FY2018FY2019FY2019FY2021FY2022FY2023FY2024
Cash and equivalents46,45538,72232,90551,65424,36940,23723,90725,21116,17710,011
Short-term investments32610015020720025
Receivables24,43633,76124,05622,43622,05321,79026,25526,08631,612
Inventory3,9332,8783,4124,0853,6623,5683,3403,306
Total current assets85,96489,66999,57475,57787,43873,93181,32970,12363,828
Property, plant and equipment195,782203,188186,907195,964232,134260,868302,736292,745287,103318,069
Lease right-of-use assets15,89018,30320,08128,86332,71739,111
Goodwill61,37961,37961,37961,37961,37961,37962,94162,94162,941
Intangible assets8,9018,2047,2046,4463,9501,1561,6081,3941,523
Total assets455,095475,119459,444482,750525,027575,846626,328624,162609,519623,275
Accounts payable52,95060,44574,61077,84582,41399,718105,18781,01466,722
Short-term debt00010,000
Total current liabilities182,013168,091192,608204,448213,537224,274247,002196,673188,462
Lease liabilities13,10015,98217,13131,95841,62546,703
Total liabilities341,197366,582348,261366,084408,737456,181498,863510,201499,133506,540
Total debt185,032172,611176,276192,556222,765252,557249,580254,798281,586
Retained earnings3,48363412,08118,06325,65234,24318,79922,02033,901
Shareholders' equity108,175106,842112,358111,987115,408123,216108,727105,218115,419
Minority interests3624,3414,3084,3034,2574,2495,2345,1681,316
Total equity113,898108,537111,183116,666116,290119,665127,465113,961110,386116,735
Total liabilities and equity455,095475,119459,444482,750525,027575,846626,328624,162609,519623,275

Cash flow statement

FY2015FY2017FY2017FY2018FY2019FY2019FY2021FY2022FY2023FY2024
Net income22,07520,16213,46618,97322,78624,58026,67610,73526,82432,555
Depreciation and amortization31,51934,45551,91547,24039,65647,48052,07298,63158,44155,988
Cash from operations69,74448,97656,11461,11669,39285,07691,97076,20085,76581,731
Capital expenditures-42,805-42,259-36,616-47,247-88,246-76,503-102,395-93,803-76,266-65,668
Cash from investing-39,238-41,982-21,060-25,054-84,316-68,669-103,640-33,006-55,118-65,704
Debt issued44,36740,56926,25520,50037,50061,27151,5005,00038,00037,000
Debt repaid-17,084-19,650-39,199-18,740-20,494-28,365-22,565-22,353-22,611-12,059
Share buybacks-1
Dividends paid-32,532-22,987-16,617-13,928-15,592-16,721-17,712-25,235-23,328-20,750
Cash from financing-11,385-15,341-40,319-18,144-11,613463-4,904-42,304-39,418-22,331
Exchange rate effect675614-552831-748-1,002244414-263138
Net change in cash19,796-7,733-5,81718,749-27,28515,868-16,3301,304-9,034-6,166
Free cash flow26,9396,71719,49813,869-18,8548,573-10,425-17,6039,49916,063

Key metrics

Worked out from the statements above. Latest values use fiscal 2024. No valuation: the share price is quoted in a different currency than the statements.

Profitability

MetricValueHow it is calculated
Gross margin93.5%Gross profit / revenue.
Operating margin23.3%Operating income / revenue.
EBITDA margin49.1%EBITDA (operating income + depreciation and amortization) / revenue.
Pre-tax margin19.7%Pre-tax income / revenue.
Net margin14.9%Net income / revenue.
FCF margin7.4%Free cash flow (cash from operations - capital expenditures) / revenue.
Operating cash flow margin37.7%Cash from operations / revenue.
Effective tax rate23.7%Income tax / pre-tax income, when pre-tax income is positive.
Return on equity (ROE)29.3%Net income / average shareholders' equity (opening and closing). Not shown when equity is negative.
Return on assets (ROA)5.2%Net income / average total assets.
Return on invested capital (ROIC)10.5%Approximation: operating income x (1 - tax rate) / average (total debt + equity - cash). Tax rate is the effective rate when between 0% and 50%, else 21%.
SG&A / revenue36.1%Selling, general and administrative expense / revenue.
Capex / revenue30.3%Capital expenditures / revenue.
D&A / revenue25.8%Depreciation and amortization / revenue.

Growth

MetricValueHow it is calculated
Revenue growth, 1y2.8%Revenue vs the same period a year earlier. Only from a positive base.
Revenue CAGR, 3y4.1%Compound annual growth of revenue over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Revenue CAGR, 5y5.1%Compound annual growth of revenue over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Gross profit growth, 1y3.6%Gross profit vs the same period a year earlier. Only from a positive base.
Gross profit CAGR, 3y4.2%Compound annual growth of gross profit over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Gross profit CAGR, 5y5.4%Compound annual growth of gross profit over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Operating income growth, 1y24.1%Operating income vs the same period a year earlier. Only from a positive base.
Operating income CAGR, 3y7.3%Compound annual growth of operating income over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Operating income CAGR, 5y5.1%Compound annual growth of operating income over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
EBITDA growth, 1y7.4%EBITDA vs the same period a year earlier. Only from a positive base.
EBITDA CAGR, 3y4.6%Compound annual growth of ebitda over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
EBITDA CAGR, 5y6.1%Compound annual growth of ebitda over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Net income growth, 1y21.4%Net income vs the same period a year earlier. Only from a positive base.
Net income CAGR, 3y7.0%Compound annual growth of net income over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Net income CAGR, 5y7.5%Compound annual growth of net income over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
EPS growth, 1y21.4%EPS vs the same period a year earlier. Only from a positive base.
EPS CAGR, 3y7.0%Compound annual growth of eps over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
EPS CAGR, 5y7.5%Compound annual growth of eps over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Operating cash flow growth, 1y-4.7%Operating cash flow vs the same period a year earlier. Only from a positive base.
Operating cash flow CAGR, 3y-3.9%Compound annual growth of operating cash flow over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Operating cash flow CAGR, 5y3.3%Compound annual growth of operating cash flow over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Free cash flow growth, 1y69.1%Free cash flow vs the same period a year earlier. Only from a positive base.
Book value growth, 1y9.7%Book value vs the same period a year earlier. Only from a positive base.
Book value CAGR, 3y-2.2%Compound annual growth of book value over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Book value CAGR, 5y0.6%Compound annual growth of book value over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Total assets growth, 1y2.3%Total assets vs the same period a year earlier. Only from a positive base.
Total assets CAGR, 3y-0.2%Compound annual growth of total assets over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Total assets CAGR, 5y3.5%Compound annual growth of total assets over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.

Balance sheet health

MetricValueHow it is calculated
Current ratio0.34xCurrent assets / current liabilities.
Quick ratio0.22x(Cash + short-term investments + receivables) / current liabilities.
Cash ratio0.05x(Cash + short-term investments) / current liabilities.
Debt / equity2.44xTotal debt / shareholders' equity. Not shown when equity is negative.
Debt / assets45.2%Total debt / total assets.
Liabilities / assets81.3%Total liabilities / total assets.
Net debt₱271.55BTotal debt - cash - short-term investments. Negative means more cash than debt.
Net debt / EBITDA2.55xNet debt / EBITDA (twelve months), when EBITDA is positive.
Interest coverage3.26xOperating income / interest expense.
Working capital-₱124.63BCurrent assets - current liabilities.
Goodwill and intangibles / assets10.3%(Goodwill + intangible assets) / total assets.
Tangible book value₱50.96BShareholders' equity - goodwill - intangible assets.

Efficiency

MetricValueHow it is calculated
Asset turnover0.35xRevenue / average total assets.
Fixed asset turnover0.72xRevenue / average property, plant and equipment.
Inventory turnover4.22xCost of revenue / average inventory.
Days inventory87 days365 x average inventory / cost of revenue.
Receivables turnover7.52xRevenue / average receivables.
Days sales outstanding49 days365 x average receivables / revenue.
Days payables1,924 days365 x average accounts payable / cost of revenue.
Cash conversion cycle-1,789 daysDays inventory + days sales outstanding - days payables.
FCF conversion49.7%Free cash flow / net income, when net income is positive.
Capex / operating cash flow80.3%Capital expenditures / cash from operations, when that is positive.

Per share

MetricValueHow it is calculated
EPS, diluted₱149.26Net income per diluted share, as reported (split-adjusted). Over the last twelve months: the four quarters summed, or net income / latest diluted shares when a quarter has no reported EPS.
EPS, basic₱149.26Net income per basic share, as reported (split-adjusted).
Payout ratio64.2%Dividends paid / net income, when net income is positive.
Dividends / FCF129.2%Dividends paid / free cash flow, when free cash flow is positive.
What was PLDT Inc.'s revenue in fiscal 2024?

PLDT Inc. reported revenue of ₱216.83B for fiscal 2024, 2.8% higher than the year before.

Was PLDT Inc. profitable in fiscal 2024?

Yes. Net income was ₱32.31B, a net margin of 14.9%.

How much free cash flow did PLDT Inc. generate in fiscal 2024?

Cash from operations of ₱81.73B minus capital expenditures of ₱65.67B left free cash flow of ₱16.06B.

Source: SEC EDGAR XBRL company facts. Where a company tags only year-to-date figures, quarters are worked out as differences. Where a line is not tagged it is left empty, never estimated.

Open interactive statements, quarterly figures and charts

Back to PLDT Inc.